Latent tuberculosis reactivation in a patient with erythrodermic psoriasis under treatment with ustekinumab and a low dose steroid, despite isoniazid chemoprophylaxis

Eur J Dermatol. 2014 Jul-Aug;24(4):508-9. doi: 10.1684/ejd.2014.2386.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antitubercular Agents / therapeutic use*
  • Chemoprevention
  • Dermatologic Agents / adverse effects*
  • Drug Therapy, Combination
  • Glucocorticoids / administration & dosage
  • Humans
  • Isoniazid / therapeutic use*
  • Latent Tuberculosis / complications*
  • Male
  • Prednisone / administration & dosage
  • Psoriasis / complications*
  • Psoriasis / drug therapy*
  • Tuberculosis, Miliary / complications
  • Tuberculosis, Miliary / drug therapy
  • Tuberculosis, Pulmonary / complications
  • Tuberculosis, Pulmonary / drug therapy
  • Ustekinumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Antitubercular Agents
  • Dermatologic Agents
  • Glucocorticoids
  • Ustekinumab
  • Isoniazid
  • Prednisone